All times are in Pacific Standard Time. Program is subject to change. Last updated 2/25/2021.
| Day 1: March 8, 2020 | ||
| Start Time | End Time | |
| 8:00 AM | 8:10 AM | Welcome Remarks: Cleo/Greg |
| 8:10 AM | 8:50 AM | Keynote: Development of REGN-COV2, an anti-spike antibody cocktail for treatment and prevention of COVID-19 Alina Baum, Regeneron |
| 8:50 AM | 9:00 AM | Break |
| Session 1: Speed to Clinic (and launch) | ||
| 9:00 AM | 9:05 AM | Session Intro & Brian Kelley |
| 9:05 AM | 9:25 AM | Delivering Therapeutic Mabs for COVID-19: What Can be Done in Just One Year? Brian Kelley, VIR Biotechnology |
| 9:25 AM | 9:45 AM | Bryan Harmon, Eli Lilly and Company |
| 9:45 AM | 10:05 AM | Enabling Development of a COVID-19 Neutralizing Antibody Cocktail on Pandemic Timelines with Platform Technologies from Ebola Shawn Lawrence, Regeneron |
| 10:05 AM | 10:10 AM | Break |
| 10:10 AM | 10:30 AM | Breaking Records in CMC Timelines for Development and Manufacturing of anti COVID-19 Neutralizing mAbs Weichang Zhou, WuXi Biologics |
| 10:30 AM | 10:50 AM | Bioshield - a Parallel Drug Development Platform Approach, Reduces Time to IND for Antibody Therapeutics to <4 Months Nandu Budigi, Tychan Pte Ltd |
| 10:50 AM | 11:30 AM | Q&A Panel Discussion |
| 11:30 AM | 12:00 PM | Break out |
| 12:00 PM | 12:10 PM | Break |
| 12:10 PM | 12:50 PM | Poster Session |
| Day 2: March 9, 2020 | ||
| Start Time | End Time | |
| 8:00 AM | 8:10 AM | Welcome Remarks - Conference Chairs |
| 8:10 AM | 8:50 AM | Keynote: Accelerating the Pace of Vaccine Development During a Pandemic – and After Peter Marks, FDA |
| 8:50 AM | 9:00 AM | Break |
| Session 2: Speed to Launch | ||
| 9:00 AM | 9:25 AM | Enabling Speed to Launch: Our Aspiration for Patients and Staff Tongtong Wang, Genentech |
| 9:25 AM | 9:50 AM | CMC Speed Under Pressure - Merck's COVID-19 Live Virus Vaccine Pandemic Response Natalie Christian, Merck |
| 9:50 AM | 9:55 AM | Break |
| 9:55 AM | 10:20 AM | Speed-to-launch enabled through agile operational readiness in manufacturing plants Paul Lewus, Amgen |
| 10:20 AM | 10:45 AM | Leveraging Technology Investments to Enable Speed to Launch Ranga Godavarti, Pfizer |
| 10:45 AM | 11:15 AM | Panel Discussion |
| 11:15 AM | 12:00 PM | Break out |
| 12:00 AM | 12:10 PM | Break |
| 12:10 PM | 12:50 PM | Poster Session |
| Day 3: March 10, 2020 | ||
| Start Time | End Time | |
| 8:00 AM | 8:10 AM | Welcome Remarks - Conference Chairs |
| 8:10 AM | 8:50 AM | Keynote: Julie Gerberding, Merck |
| 8:50 AM | 9:00 AM | Break |
| Session 3: Supply Chain & Logistics | ||
| 9:00 AM | 9:25 AM | Maintaining Reliable Supply of Trulicity©, a High Volume Key Growth Product, during the COVID-19 Pandemic Jessica Phillips, Eli Lilly and Company |
| 9:25 AM | 9:50 AM | The Impact of COVID-19 Therapeutic Manufacturing on Global Biomanufacturing Capacity Doug Miller, BDO |
| 9:50 AM | 9:55 AM | Break |
| 9:55 AM | 10:20 AM | The Unique Supply Chain Challenges of Delivering CAR T Cell Therapies Stephen Hardt, Allogene |
| 10:20 AM | 10:45 AM | Delivering Hope (The COVID-19 Vaccine Clinical Supply Chain Journey) Michael Ku, Pfizer |
| 10:45 AM | 11:15 AM | Panel Discussion |
| 11:15 AM | 11:45 PM | Break out |
| 11:45 AM | 12:05 PM | Closing Remarks - Conference Chairs |